Sulfinpyrazone is a uricosuric agent that competitively inhibits uric acid (Item No. 16219) reabsorption in kidney proximal tubules, which is a key mechanism targeted in the treatment of gout.{28606,28995} It can also inhibit degranulation of platelets, reducing the release of ADP and thromboxane and diminishing platelet aggregation.{28994}
产品描述
A uricosuric agent that competitively inhibits uric acid reabsorption in kidney proximal tubules, which is a key mechanism targeted in the treatment of gout; inhibits degranulation of platelets, reducing the release of ADP and thromboxane and diminishing platelet aggregation